Accuracy of the Dexcom G7 Continuous Glucose Monitoring System Following Cardiac Surgery
Launched by THE CLEVELAND CLINIC · Mar 29, 2024
Trial Information
Current as of July 21, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is looking at how well the Dexcom G7 Continuous Glucose Monitoring System works compared to traditional methods of checking blood sugar levels in patients who have just had heart surgery. During the study, participants will have their blood sugar measured every 1-3 hours using both the continuous glucose monitor and a fingerstick test, which is a common method where a small drop of blood is taken from a fingertip. The goal is to see how closely the two methods agree with each other and to identify any errors in the readings.
To be eligible for this trial, participants must be 18 years or older and have planned heart surgery. They can have diabetes or not, but most patients in the intensive care unit will need extra insulin due to high blood sugar levels. Important factors that would exclude someone from participating include allergies to the continuous glucose monitor materials, certain skin conditions, pregnancy, or if they are using special heart devices. Participants can expect to have their blood sugar monitored closely during their hospital stay, helping researchers gather valuable information about glucose monitoring after surgery.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Age 18 years old and above
- • Planned cardiothoracic surgery
- • Planned admission to Cleveland Clinic Main Campus building J5 or J6 or Q5 cardiovascular intensive care unit (CVICU) followed by transfer to the step down unit
- • With or without known diabetes (as 75% of patients entering the CVICU have hyperglycemia requiring intravenous insulin infusion)
- • If with known diagnosis of diabetes, diabetes can be type 1, type 2, or secondary (such as due to glucocorticoids or pancreatitis
- Exclusion Criteria:
- • Allergy to the material of the continuous glucose monitoring systems (CGMS) or the adhesive to be used
- • Skin conditions precluding the use of the CGMS
- • Pregnancy
- • Other conditions that the investigators deem inappropriate for the study
- • Patients receiving mechanical circulatory assist devices
About The Cleveland Clinic
The Cleveland Clinic is a renowned nonprofit academic medical center based in Cleveland, Ohio, recognized for its commitment to advancing healthcare through innovative research and clinical excellence. As a leading sponsor of clinical trials, the Cleveland Clinic leverages its multidisciplinary expertise and state-of-the-art facilities to conduct groundbreaking studies aimed at improving patient outcomes across a wide range of medical conditions. With a strong emphasis on patient-centered care, the institution fosters collaboration among researchers, clinicians, and patients to explore new treatments and therapies, contributing significantly to the global body of medical knowledge.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Cleveland, Ohio, United States
Patients applied
Trial Officials
Lansang Cecilia, MD
Principal Investigator
The Cleveland Clinic
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported